Yan Niu | Pharmaceutical Chemistry | Research Excellence Award

Published on by Top Pharmaceutical

Prof. Yan Niu | Pharmaceutical Chemistry | Research Excellence Award

Peking University | China

Prof. Yan Niu has established a solid and credible scholarly footprint within the global pharmaceutical sciences community, as demonstrated by his citation performance and publication metrics. His research portfolio comprises 46 peer-reviewed scientific documents, published in reputable international journals indexed in major databases such as Scopus and SCI. These publications collectively have attracted 538 citations, reflecting sustained academic attention and continued relevance of his work. Importantly, these citations originate from 447 independent citing documents, indicating that his research has been widely referenced across diverse studies rather than concentrated within a narrow citation network.An h-index of 14 further illustrates the balance between productivity and impact in Prof. Niu’s academic career. This metric signifies that at least fourteen of his publications have each received a minimum of fourteen citations, underscoring consistent influence across multiple research outputs rather than reliance on a small number of highly cited papers. Such a profile is characteristic of researchers whose work contributes foundational knowledge and methodological innovation to their field.The citation impact of Prof. Niu’s publications is closely aligned with the scientific significance of his research areas, particularly targeted protein degradation, amino acid-based hydrophobic tagging strategies, and the discovery and optimization of biologically active small molecules. These topics are at the forefront of modern drug discovery, attracting interdisciplinary interest from medicinal chemists, pharmacologists, and translational researchers. Collectively, his citation metrics not only quantify academic recognition but also reflect the practical and conceptual value of his contributions to advancing innovative therapeutic strategies and expanding the chemical biology toolkit available to pharmaceutical research.

Citation Metrics (Scopus)

600

450

300

150

0

Citations
538

Documents
46

h-index
14


View Scopus Profile

Featured Publications

Amirhosein Kefayat | Pharmaceutical Chemistry | Top Pharmaceutical Scientist Award

Published on by Top Pharmaceutical

Dr. Amirhosein Kefayat | Pharmaceutical Chemistry | Top Pharmaceutical Scientist Award

Edinburgh of University | United Kingdom

Dr. Amirhosein Kefayat is a distinguished physician-scientist specializing in oncology, nanomedicine, cancer immunotherapy, and radiation oncology, with extensive experience in translational research and clinical studies. He earned his Doctorate of Medicine (MD) from Isfahan University of Medical Sciences in 2019 and has since advanced his qualifications with multiple prestigious certifications, including full registration with the General Medical Council (UK) and ongoing ECFMG certification for the United States.Currently serving as a Clinical Research Fellow at the Institute of Genetics & Cancer, University of Edinburgh & NHS Lothian (UK), Dr. Kefayat contributes to UK-wide clinical trials such as ACESO, BIOPIC, DEFINE, PROFILE, PAN-IBD, and Gut Cell Atlas. He also leads systematic review and meta-analysis teams, influencing major clinical guidelines like the British Society of Gastroenterology 2024 update.Previously, as a Clinical Research Fellow at the Dept. of Radiotherapy & Oncology, Arak University of Medical Sciences (Iran), he led multiple high-impact research projects, resulting in numerous publications, international conference presentations, patents, and national research grants (INSF, NIMAD).Dr. Kefayat has published extensively in top Q1 journals such as Carbohydrate Polymers, Biosensors & Bioelectronics, Vaccine, Scientific Reports, Journal of Biomolecular Structure & Dynamics, and Nanomedicine. His work on novel cancer vaccines, wound healing biomaterials, and radiosensitizers ranks among the top 1–10% most-cited papers worldwide, reflecting his global research impact.His notable accolades include recognition as the top 0.5% of scholars worldwide (2024), membership in Iran’s National Elites Foundation, and multiple national research grants. His patented biomaterial for diabetic wound healing demonstrates his commitment to bridging laboratory research with clinical application.

Profile: Google Scholar

Featured Publications

Eskandarinia, A., Kefayat, A., Agheb, M., Rafienia, M., & Amini Baghbadorani, M. (2020). A novel bilayer wound dressing composed of a dense polyurethane/propolis membrane and a biodegradable polycaprolactone/gelatin nanofibrous scaffold. Scientific Reports, 10(1), 3063.

Eskandarinia, A., Kefayat, A., Gharakhloo, M., Agheb, M., Khodabakhshi, D., Rafienia, M., & Navid, S. (2020). A propolis enriched polyurethane-hyaluronic acid nanofibrous wound dressing with remarkable antibacterial and wound healing activities. International Journal of Biological Macromolecules, 149, 467–476.

Safavi, A., Kefayat, A., Mahdevar, E., Abiri, A., & Ghahremani, F. (2020). Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Vaccine, 38(48), 7612–7628.

Khodabakhshi, D., Eskandarinia, A., Kefayat, A., Rafienia, M., Navid, S., & Agheb, M. (2019). In vitro and in vivo performance of a propolis-coated polyurethane wound dressing with high porosity and antibacterial efficacy. Colloids and Surfaces B: Biointerfaces, 178, 177–184.

Eskandarinia, A., Kefayat, A., Rafienia, M., Agheb, M., Navid, S., & Ebrahimpour, K. (2019). Cornstarch-based wound dressing incorporated with hyaluronic acid and propolis: In vitro and in vivo studies. Carbohydrate Polymers, 216, 25–35.

Karizmeh, M. S., Poursamar, S. A., Kefayat, A., Farahbakhsh, Z., & Rafienia, M. (2022). An in vitro and in vivo study of PCL/chitosan electrospun mat on polyurethane/propolis foam as a bilayer wound dressing. Biomaterials Advances, 135, 112667.

Ghahremani, F., Shahbazi-Gahrouei, D., Kefayat, A., Motaghi, H., & Amouheidari, A. (2018). AS1411 aptamer conjugated gold nanoclusters as a targeted radiosensitizer for megavoltage radiation therapy of 4T1 breast cancer cells. RSC Advances, 8(8), 4249–4258.

Safavi, A., Kefayat, A., Abiri, A., Mahdevar, E., Behnia, A. H., & Ghahremani, F. (2019). In silico analysis of transmembrane protein 31 (TMEM31) antigen to design novel multiepitope peptide and DNA cancer vaccines against melanoma. Molecular Immunology, 112, 93–102.

Shu-Rong Ban | Pharmaceutical Chemistry | Excellence in Research Award

Published on by Top Pharmaceutical

Prof. Shu-Rong Ban | Pharmaceutical Chemistry | Excellence in Research Award

Shanxi Medical University | China

Prof. Shu-Rong Ban is a distinguished scholar in the field of medicinal chemistry with a solid academic foundation and a long-standing commitment to research, teaching, and scientific innovation. He began his academic journey at Tianjin Normal University, where he obtained his bachelor’s degree, and later pursued a combined master’s and doctoral program at Nankai University, successfully earning his doctorate. His professional career has been deeply rooted in the School of Pharmacy at Shanxi Medical University, where he advanced through the ranks from lecturer to associate professor and later professor, reflecting his dedication and contributions to the field. He also enriched his academic perspective through international exposure as a visiting scholar at McGill University in Canada and at the Beijing Institute of Technology, experiences that expanded his research horizons and fostered collaborative ties with leading researchers worldwide.Prof. Ban has been actively involved in academic leadership and professional service. He holds memberships and leadership positions in multiple professional organizations, including serving as a member of the Pharmacy Education Professional Committee of the Chinese Pharmaceutical Association, director of the Shanxi Pharmaceutical Association, deputy director of its Academic Working Committee, and director of the Shanxi Chemical Society. His academic excellence has been recognized through honors such as the Shanxi Provincial Science and Technology Progress Award, the “Three Educations” Advanced Individual Award of Shanxi Medical University, and the Excellent Graduate Tutor distinction, reflecting both his research achievements and commitment to education.In teaching, Prof. Ban has played a key role in shaping pharmacy education, offering undergraduate courses such as Organic Chemistry, Organic Chemistry Experiment, and Professional English, as well as postgraduate courses including Progress in Pharmacy, Introduction to the Frontier of Medicinal Chemistry, and Pharmaceutical Preparation Technology. Notably, his course on Organic Chemistry was selected as a Shanxi Provincial First-Class Course, highlighting his innovation in teaching methodology and curriculum design.

Profile: Orcid

Featured Publications

Guo, L., Kang, S., Liu, J., Ma, Y., Tian, Y., Wang, B., Ma, S., Li, L., Yan, L., Zhang, C., & Liu, W., et al. (2024). Activatable near-infrared fluorescent/photoacoustic probe for rapid identification of β-lactam-resistant bacteria. Microchemical Journal.

Ge, R., Song, J., Cao, Z., Ban, S., Tang, L., & Li, Q. (2024). Discovery of 6-acylamino/sulfonamido benzoxazolone with IL-6 inhibitory activity as promising therapeutic agents for ulcerative colitis. Chemistry & Biodiversity.

Liu, J., Li, X., Xie, S., Ma, R., Wang, H., Ban, S., Zhang, C., & Guo, L. (2024). Fabricating a PDA-NOate@CuS coated NIR-activatable titanium implant to realize simultaneous antiinfection and osseointegration. New Journal of Chemistry.

Yao, J., Li, C., Feng, J., Wei, B., Xing, R., Ban, S., Tang, L., & Liu, B. (2024). Mn-doped CeO₂ nanorods for the colorimetric sensing of glutathione. ACS Applied Nano Materials.

Liu, Y., Fu, Z., Yang, C., Luo, M., Ban, S., & Wang, S. (2024). Rh(III)-catalyzed aminoalkylation of alkenes with diazo compounds toward functionalized isoindolinones. Chinese Journal of Organic Chemistry.

Meng, S., Cao, Z., Bai, H., Ge, R., Ban, S., Tang, L., & Li, Q. (2023). Antinociceptive action of 4-(5′-dimethylamino)-naphthalenesulfonyl-2(3H)-benzoxazolone (W3D) on animal models of pain via inhibitory effects on NO and iNOS. Natural Product Communications.

Li, G., Zhang, H., Zhang, G., Wei, B., Liu, B., Song, H., Li, Q., & Ban, S. (2023). Asymmetric synthesis of spiropyrazolone-fused dihydrofuran-naphthoquinones bearing contiguous stereocenters via a Michael addition/chlorination/nucleophilic substitution sequence. Journal of Organic Chemistry.

Prof Dr.Christophe LEN| Pharmaceutical Chemistry|Excellence in Research

Published on by Top Pharmaceutical

Prof Dr.Christophe LEN,Pharmaceutical Chemistry ,Excellence in Research

Prof Dr.Christophe LEN, at Chimie ParisTech, France

 Profiles

Scopus

Orcid

🎓Early Academic Pursuits

Professor Dr. Christophe Len’s academic journey began at Université de Picardie Jules Verne in Amiens, France, where he completed his Master of Science (MsC) in Chemistry in 1992. His pursuit of advanced knowledge continued as he earned his PhD in Chemistry from the same institution in 1995. Following his doctoral studies, Dr. Len undertook a post-doctoral fellowship at the University of Hull in England from 1996 to 1997. This period was crucial in shaping his research trajectory and establishing a solid foundation in organic chemistry and catalysis.

🏢Professional Endeavors

Dr. Len’s career is marked by a series of esteemed positions across prominent institutions. He began his academic career as an Assistant Professor at Université de Picardie Jules Verne in 1997. His exceptional contributions led to his rapid ascension in the academic hierarchy, securing a Full Professor position at Université de Poitiers in 2004. Subsequently, he moved to Université de Technologie de Compiègne, where he has served in various capacities, including Full Professor (second class) in 2008 and Full Professor (first class) in 2011. His current role as a Full Professor (Exceptional class) at Chimie ParisTech and Université de Technologie de Compiègne reflects his significant impact and leadership in the field.

🔬Contributions and Research Focus

Dr. Len’s research primarily revolves around innovative approaches in organic chemistry and catalysis. He is renowned for his work in continuous flow chemistry, which enhances the efficiency and sustainability of chemical processes. His expertise extends to applying cutting-edge technologies such as microwave, ultrasound, and ball milling to catalysis, both homogeneous and heterogeneous. His pioneering research on micellar catalysis has further advanced the field, demonstrating his commitment to exploring and developing new methodologies in chemistry.

🏆Accolades and Recognition

Professor Len’s outstanding contributions have earned him numerous accolades and recognition. In 2017, he was honored with the Glycerine Innovation Research Award by the American Oils Chemists’ Society (AOCS). His scholarly excellence has been recognized through various honorary appointments, including Honorary Professor at the University of Hull (2012-2018) and Honorary Professor at Xi’an Jiaotong University, China (2022-2025). He is also a Fellow of the Royal Society of Chemistry (FRSC) and holds honorary life fellowships with the Association of Carbohydrate Chemists and Technologists India (ACCTI) and the Indian Society of Chemists and Biologists (ISCB).

Dr. Len’s editorial roles reflect his influence in the field: he is a member of the editorial boards for several prestigious journals, including Sustainability (Sust. Chem. Eng. Technol.), Material Chemistry (Materials), Biomass Catalysis (Catalysts), and Green Chemistry (Molecules). His service on the management committee for the COST Action FP1306 and the CNRS GDR2053 Synth-Flux further underscores his leadership in advancing green chemistry and flow synthesis technologies.

🌟Impact and Influence

With an impressive h-index of 49 (Scopus) and 51 (Google Scholar), Dr. Len’s work has had a profound impact on the field of chemistry. His research, which includes over 250 peer-reviewed journal articles, 11 patents, and 13 book chapters, has garnered significant attention and citation, reflecting the relevance and quality of his contributions. His extensive participation in conferences and oral communications, as well as his prolific output in posters, showcases his active engagement with the scientific community and his role in disseminating knowledge.

🌍Legacy and Future Contributions

Dr. Len’s legacy is marked by his transformative contributions to organic chemistry and catalysis. His innovative approaches and dedication to advancing chemical processes have set new standards in the field. Looking ahead, his ongoing work in continuous flow chemistry and green chemistry continues to shape the future of sustainable chemical practices. His involvement in global research clusters and editorial boards highlights his commitment to fostering collaboration and driving progress in chemistry.

Professor Dr. Christophe Len’s career exemplifies excellence and innovation in the scientific community. His contributions not only advance fundamental chemistry but also pave the way for future research and applications, solidifying his position as a leading figure in his field.

🎓Publication 

Photocatalytic oxidative desulfurization with Anderson-type polyoxometalates nanoclusters doped carbon nitride

  • Authors   :Zhao, D., Liu, Q., Lü, H., Zhao, J., Len, C.
  • Journal    :Colloids and Surfaces A: Physicochemical and Engineering Aspects
  • Year         : 2024

Glycerol: A green solvent for synthetic chemistry

    • Authors : de Nazaré de Oliveira, A., Melchiorre, M., Farias da Costa, A.A., Santos do Nascimento, L.A., Len, C.
    • Journal   :Sustainable Chemistry and Pharmacy
    • Year       : 2024
Robust synergistic effect between Zn1Mo1 bifunctional TiO2 for efficient ethyl levulinate production from furfural alcohol
  • Authors  :Si, Q., Zhao, D., Yang, Z., Zhao, J., Zhang, H.
  • Journal    :Materials Today Chemistry
  • Year         :  2024
Anderson-type polyoxometalates support on orange peel activated carbon for efficient ethyl levulinate production
  • Authors  : Zhao, D., Zhang, S., Si, Q., Xu, Y., Zhang, H.
  • Journal   :Fuel
  • Year        :   2024

Green and efficient deep eutectic solvent mediated one-step synthesis of Suxamethonium Chloride as Active Pharmaceutical Ingredient

  • Authors  : Sagandira, C.R., Nguyen, R., Liu, Q., Len, C.
  • Journal   :Sustainable Chemistry and Pharmacy
  • Year        : 2024